As a consequence of unique pharmacokinetic profiles, oral formulations are usually not interchangeable with prolonged release on an mg-mg foundation due to unique pharmacokinetic profiles Jun 10, 2024 · If clonidine therapy should be to be replaced by a β-blocker, hold off ad